| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LOPINAVIR AND RITONAVIR | 205425 | 001 | NDA | LOPINAVIR;RITONAVIR | PELLETS;ORAL | 40MG;10MG | No | No | 2015/05/21 (TA) | -- | CIPLA LTD | None (Tentative Approval) |
| LOPINAVIR AND RITONAVIR | 207407 | 001 | ANDA | LOPINAVIR; RITONAVIR | SOLUTION;ORAL | 80MG/ML;20MG/ML | No | No | 2016/12/27 | 2016/12/27 | LANNETT CO INC | Prescription |
| LOPINAVIR AND RITONAVIR | 091677 | 001 | ANDA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 100MG;25MG | No | No | 2021/06/04 | 2021/06/04 | HETERO LABS LTD III | Prescription |
| LOPINAVIR AND RITONAVIR | 091677 | 002 | ANDA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 200MG;50MG | No | No | 2021/06/04 | 2021/06/04 | HETERO LABS LTD III | Prescription |
| LOPINAVIR AND RITONAVIR | 213857 | 001 | ANDA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 100MG;25MG | No | No | 2022/03/21 | 2022/03/21 | LAURUS | Prescription |
| LOPINAVIR AND RITONAVIR | 213857 | 002 | ANDA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 200MG;50MG | No | No | 2022/03/21 | 2022/03/21 | LAURUS | Prescription |
| LOPINAVIR AND RITONAVIR | 079074 | 001 | ANDA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 100MG;25MG | No | No | 2024/02/07 | 2024/02/07 | MYLAN LABS LTD | Prescription |
| LOPINAVIR AND RITONAVIR | 079074 | 002 | ANDA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 200MG;50MG | No | No | 2024/02/07 | 2024/02/07 | MYLAN LABS LTD | Prescription |
| LOPINAVIR AND RITONAVIR | 204739 | 001 | ANDA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 100MG;25MG | No | No | 2024/07/25 | 2024/07/25 | MACLEODS PHARMS LTD | Prescription |
| LOPINAVIR AND RITONAVIR | 204739 | 002 | ANDA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 200MG;50MG | No | No | 2024/07/25 | 2024/07/25 | MACLEODS PHARMS LTD | Prescription |